Affective disorder treatments and second messengers in the brain

Author： Moslashrk A. Jensen J.B. Petersen B. Thrane J. Geisler A.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 167-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New treatments for bipolar disorder

By Tohen M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 228-229

Elsevier

Access to resources Recommend Favorite

Novel treatments for bipolar disorder

By Bowden C.L.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 661-671

Informa Healthcare

Access to resources Recommend Favorite

Bupropion for the treatment of seasonal affective disorder

By Niemegeers Peter

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1229-1240

Informa Healthcare

Access to resources Recommend Favorite

Study of anticipation in bipolar affective disorder

By Heiden A.M. Miller-Reiter E. Willinger U. Meszaros K. Scharfetter J. Lenzinger E. Resinger E. Aschauer H.N. Kasper S.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 271-272

Elsevier

Access to resources Recommend Favorite

Agomelatine in the treatment of seasonal affective disorder

By Pjrek Edda Winkler Dietmar Konstantinidis Anastasios Willeit Matthäus Praschak-Rieder Nicole Kasper Siegfried

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 575-579

Springer Publishing Company

Access to resources Recommend Favorite